Microsaic Systems plc Update (5834Y)
04 Januar 2024 - 8:00AM
UK Regulatory
TIDMMSYS
RNS Number : 5834Y
Microsaic Systems plc
04 January 2024
4 January 2024
Microsaic Systems plc
("Microsaic" or the "Company")
Update
Capitalised terms in this announcement carry the same meaning as
in the Circular
or subsequent announcements, unless the context indicates
otherwise
Microsaic Systems plc (AIM: MSYS), the developer of
micro-electronic instruments and analytical solutions, provides an
update on the Revised Fundraising and Acquisition following the
completion of the Share Consolidation and Sub-division on 2 January
2024.
Further to the Result of General Meeting announcement made by
the Company on 29 December 2023, Microsaic is in the process of
securing binding conditional commitments to the Placing through
Turner Pope Investments as placing agent to the Revised
Fundraising. The Company's ongoing due diligence with regard to the
Acquisition and finalisation of the terms of the Acquisition
Agreement continue to make positive progress.
A further update will be provided in the coming days in relation
to the expected timetable of principal events relating to the
Placing, Acquisition, publication of Annual Report and Interim
Results, Restoration and Admission. The Company confirms that
Cancellation will not become effective at 7.00 a.m. today as
previously anticipated.
Further to the Share Capital Reorganisation, Microsaic confirms
that the Company's new ISIN code is GB00BMWC8365. CREST accounts
have been credited with the New Ordinary Shares of 0.001 pence each
and holders of certificated shares need take no further action.
Enquiries:
Microsaic Systems plc +44 (0) 20 3657 0050
Bob Moore, Acting Executive Chairman via TPI
Singer Capital Markets (Nominated
Adviser)
Aubrey Powell / Angus Campbell
/ Oliver Platts +44 (0)20 7496 3000
Turner Pope Investments (TPI)
Limited (Broker)
Andy Thacker / James Pope +44 (0) 20 3657 0050
About Microsaic Systems
Microsaic has over 20 years' experience in microelectronics and
development of instrumentation. The Company has a robust and
innovative patent portfolio in cutting-edge technology designed and
developed for "Industry 4.0" application serving markets in
diversified Industries, Human and Environmental Health. Microsaic's
system solutions have enabled analytical detection and
characterisation at the point-of-need, whether within a
conventional laboratory setting, or within a bioprocessing facility
for continuous detection of data at multiple steps in the process
workflow.
Microsaic's products and solutions are commercially available
through global markets via a network of regional and local
partners, targeting its core laboratory, manufacturing and
point-of-need applications.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDFLFVTLFIVIIS
(END) Dow Jones Newswires
January 04, 2024 02:00 ET (07:00 GMT)
Microsaic Systems (AQSE:MSYS.GB)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Microsaic Systems (AQSE:MSYS.GB)
Historical Stock Chart
Von Nov 2023 bis Nov 2024